Akero Therapeutics, Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Akero Therapeutics, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2022 to 2023.
  • Akero Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $768K, a 175% increase year-over-year.
  • Akero Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $2.48M, a 463% increase from 2022.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.48M +$2.04M +463% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $441K Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.